Pulmonary Arterial Hypertension

The AJMC® Pulmonary Arterial Hypertension compendium is a comprehensive resource for clinical news and expert insights for the progressive disorder, which is characterized by high blood pressure in the arteries that go from the heart to the lungs.

Latest News

patient and doctor - Halfpoint - stock.adobe.com.jpeg
Refinements to European Strategy Can Improve PAH-CHD Stratification

November 6th 2024

When patients were re-classified based on the adjusted thresholds of N-terminal pro-brain natriuretic peptide and 6-minute walk distance and the inclusion of TAPSE rather than right atria area, classification of patients improved significantly.

Pulmonary hypertension | Image Credit: © Designpics - stock.adobe.com
PAH Treatment Outcomes Similar Regardless of Diagnosis Time

November 1st 2024

PAH concept | image credit: Ahmad - stock.adobe.com
Early Use of Triple Oral Therapy May Lower Hospitalizations for PAH

October 23rd 2024

Doctor holds lung model representing PAH | Image Credit: © Orawan - stock.adobe.com
Certain Immune Cells May Increase, Decrease PAH Risk

October 16th 2024

Mobility reduction may be an early sign of PAH | image credit: PrusarooYakk - stock.adobe.com
A Call for Consistent Digital Mobility Measurement Protocols in PAH

October 9th 2024

More News

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo